Mardia Samyoung

Is Mardia Samyoung overvalued or undervalued?

As of November 12, 2024, Mardia Samyoung is considered risky and overvalued with a negative PE ratio of -6.40 and EV to EBIT of -7.22, despite a 429.84% return over five years, especially when compared to peers like Hindustan Zinc and Vedanta, which have significantly better valuation metrics.

As of 12 November 2024, Mardia Samyoung's valuation grade has moved from does not qualify to risky. Given the negative PE ratio of -6.40 and EV to EBIT of -7.22, the company appears to be overvalued. The Price to Book Value stands at 1.44, indicating that the market is pricing the company higher than its book value despite its poor financial performance.<BR><BR>In comparison to its peers, Mardia Samyoung's valuation metrics are significantly worse. For instance, Hindustan Zinc has a PE ratio of 20.37, while Vedanta shows a much more attractive PE of 12.87. The stark contrast in these ratios suggests that Mardia Samyoung is not only underperforming but also overvalued relative to its industry peers. Although the stock has shown a remarkable return of 429.84% over the past five years compared to the Sensex's 143.13%, this does not mitigate the current overvaluation concerns based on its financial ratios.

What is the technical trend for Mardia Samyoung?

As of May 26, 2025, Mardia Samyoung's trend has shifted to neutral despite reaching a 52-week high of 10.12, due to a lack of qualifying indicators.

As of 26 May 2025, the technical trend for Mardia Samyoung has changed from mildly bullish to does not qualify. The current price is at the 52-week high of 10.12, but with no additional technical summary data available, it is difficult to assess the strength of the current stance. Overall, the lack of qualifying indicators suggests a neutral position at this time.

Who are the peers of the Mardia Samyoung?

Mardia Samyoung's peers include Chennai Ferrous, Hind Aluminium, Ashoka Metcast, and others, with varying management risks and growth rates. Hind Aluminium has the highest 1-year return at 16.05%, while RR Metalmakers has the lowest at -51.54%.

Peers: The peers of Mardia Samyoung are Chennai Ferrous, Hind Aluminium, Ashoka Metcast, RR Metalmakers, Utique Enterp., Bothra Metals, Rajdarshan Inds, Maitri Enterp., and Golkonda Alumin.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chennai Ferrous, while Average management risk is found at RR Metalmakers and Golkonda Alumin, and the rest have Below Average management risk. Growth is Excellent at Maitri Enterp., Average at Ashoka Metcast and Utique Enterp., and the rest have Below Average growth. Capital Structure is Excellent at Chennai Ferrous and Utique Enterp., Average at Ashoka Metcast and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Hind Aluminium at 16.05%, while the lowest is RR Metalmakers at -51.54%. Mardia Samyoung's 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include RR Metalmakers, Utique Enterp., Bothra Metals, and Golkonda Alumin.

Who are in the management team of Mardia Samyoung?

As of March 2019, the management team of Mardia Samyoung includes Ravindra Mardia (Chairman & Managing Director), Gaurav Mardia (Whole-time Director), and several independent directors: Bharat J Chouhan, Stuti Rajeshbhai Kotecha, and Lav Kumar, along with Preeti Rawat (Director) and Poonam Kanade (Company Secretary). Each member contributes to the company's governance and operations.

As of March 2019, the management team of Mardia Samyoung includes the following individuals:<BR><BR>1. Ravindra Mardia - Chairman & Managing Director<BR>2. Bharat J Chouhan - Independent Director<BR>3. Gaurav Mardia - Whole-time Director<BR>4. Stuti Rajeshbhai Kotecha - Independent Director<BR>5. Lav Kumar - Independent Director<BR>6. Preeti Rawat - Director<BR>7. Poonam Kanade - Company Secretary<BR><BR>Each member plays a distinct role within the organization, contributing to its governance and operational management.

What does Mardia Samyoung do?

Mardia Samyoung Capillary Tubes Company Ltd manufactures capillary and thin-walled pipes from various metals and operates in the Non-Ferrous Metals industry. As of March 2025, it reported no net profit and has a market cap of INR 18 Cr.

Overview:<BR>Mardia Samyoung Capillary Tubes Company Ltd manufactures capillary and thin-walled pipes and tubes made from various metals and operates in the Non-Ferrous Metals industry within the Micro Cap market segment.<BR><BR>History:<BR>The company was incorporated in October 1992 as a joint venture between Mardia Group Companies and Samyoung Jung Kwan Company of South Korea. The latest quarterly results reported are for March 2025, showing no net profit.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025)<BR>Market-cap value: INR 18 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00<BR>Industry P/E: 16<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.19<BR>Return on Equity: -6.09%<BR>Price to Book: 4.17<BR><BR>Contact Details:<BR>Address: J-55 M I D C Industrial area, Tarapur Boisar Thane Maharashtra : 401506<BR>Phone: 91-22-24969685<BR>Email: mardiamail@hotmail.com<BR>Website: N/A

Who are the top shareholders of the Mardia Samyoung?

The top shareholders of Mardia Samyoung include promoters, with Ravindra M Mardia holding 16.03%, and individual investors owning 23.38%. There are no pledged promoter holdings or foreign institutional investors, and mutual funds hold only 0.08% of the shares.

The top shareholders of Mardia Samyoung primarily include the promoters, with Ravindra M Mardia holding the highest individual stake at 16.03%. Additionally, individual investors collectively hold 23.38% of the company's shares. There are no pledged promoter holdings, and the company does not have any foreign institutional investors (FIIs) involved. Mutual funds have a minimal presence, with only two schemes holding 0.08% of the shares.

How big is Mardia Samyoung?

As of 24th July, Mardia Samyoung Capillary Tubes Company Ltd has a market capitalization of 21.00 Cr, with recent net sales of 0.00 Cr and a net profit loss of 0.01 Cr. The latest balance sheet shows shareholder's funds of 4.43 Cr and total assets of 3.62 Cr.

As of 24th July, Mardia Samyoung Capillary Tubes Company Ltd has a market capitalization of 21.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 0.00 Cr and a Net Profit loss of 0.01 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 4.43 Cr and Total Assets of 3.62 Cr.

How has been the historical performance of Mardia Samyoung?

Mardia Samyoung has not generated net sales from Mar'20 to Mar'25, with total operating income declining to 0.00 Cr, but achieved an operating profit, profit before tax, and profit after tax of 1.20 Cr in Mar'25, marking a significant turnaround. Total assets decreased to 2.54 Cr, and cash flow from operating activities was negative at -2.00 Cr, while investing activities were positive at 2.00 Cr.

Answer:<BR>The historical performance of Mardia Samyoung shows a consistent lack of revenue generation over the years, with net sales remaining at 0.00 Cr from Mar'20 to Mar'25. The company recorded minimal other operating income, peaking at 0.32 Cr in Mar'16, but has since declined to 0.00 Cr by Mar'25. Total operating income followed a similar trend, with a high of 0.33 Cr in Mar'16 and dropping to 0.00 Cr in the latest year. The total expenditure has fluctuated, reaching a high of 1.56 Cr in Mar'25, which contributed to an operating profit (PBDIT) of 1.20 Cr in the same year, a significant improvement from previous years where losses were recorded. Profit before tax also turned positive at 1.20 Cr in Mar'25, contrasting with losses in prior years. Profit after tax mirrored this trend, achieving 1.20 Cr in Mar'25. The company's equity capital has remained stable at 6.96 Cr, while reserves have fluctuated, showing a negative balance of -1.33 Cr in Mar'25. The total assets decreased to 2.54 Cr in Mar'25 from 4.55 Cr in Mar'20, indicating a reduction in overall asset value. Cash flow from operating activities was negative at -2.00 Cr in Mar'25, while cash flow from investing activities was positive at 2.00 Cr.<BR><BR>Breakdown:<BR>Mardia Samyoung has not generated any net sales from Mar'15 to Mar'25, with total operating income peaking at 0.33 Cr in Mar'16 before declining to 0.00 Cr by Mar'25. The company faced total expenditures that peaked at 1.56 Cr in Mar'25, leading to an operating profit of 1.20 Cr, a notable turnaround from previous losses. Profit before tax and profit after tax both reached 1.20 Cr in Mar'25, indicating a significant improvement in profitability. The equity capital has remained unchanged at 6.96 Cr, while reserves have shown a negative trend, ending at -1.33 Cr in Mar'25. Total assets have decreased to 2.54 Cr in Mar'25 from 4.55 Cr in Mar'20, reflecting a decline in asset value. The cash flow from operating activities was negative at -2.00 Cr, but cash flow from investing activities was positive at 2.00 Cr, indicating some investment activity despite the overall negative cash flow from operations.

How has been the historical performance of Mardia Samyoung?

Mardia Samyoung has shown minimal revenue generation, with net sales at 0.00 Cr from Mar'20 to Mar'25, though it reported a turnaround in operating profit and profit after tax to 1.20 Cr in Mar'25. Total liabilities decreased from 4.55 Cr to 2.54 Cr during the same period, while cash flow from operating activities remained negative at -2.00 Cr.

Answer:<BR>The historical performance of Mardia Samyoung shows a trend of minimal activity with no significant revenue generation over the years, as evidenced by net sales remaining at 0.00 Cr from Mar'20 to Mar'25. The company reported a total operating income of 0.33 Cr in Mar'16, which has since declined to 0.00 Cr by Mar'25. Operating profit (PBDIT) has fluctuated, with a notable improvement to 1.20 Cr in Mar'25 from a loss of -0.24 Cr in Mar'20. Profit after tax also turned positive in Mar'25 at 1.20 Cr, contrasting with losses in previous years. The company's total liabilities decreased from 4.55 Cr in Mar'20 to 2.54 Cr in Mar'25, while total assets also declined from 4.55 Cr to 2.54 Cr in the same period. Cash flow from operating activities remained negative at -2.00 Cr in Mar'25, despite a positive cash flow from investing activities of 2.00 Cr.<BR><BR>Breakdown:<BR>Mardia Samyoung has demonstrated a lack of revenue generation, with net sales consistently at 0.00 Cr from Mar'20 to Mar'25. The total operating income peaked at 0.33 Cr in Mar'16 but has since fallen to 0.00 Cr. Operating profit showed a significant turnaround in Mar'25, reaching 1.20 Cr, a stark contrast to the losses recorded in prior years. Profit after tax also improved to 1.20 Cr in Mar'25, indicating a positive shift in financial performance. The company's total liabilities have decreased significantly from 4.55 Cr in Mar'20 to 2.54 Cr in Mar'25, while total assets have mirrored this decline. Cash flow from operating activities remained negative at -2.00 Cr in Mar'25, although the company reported a positive cash flow from investing activities of 2.00 Cr, suggesting some level of investment activity despite overall financial challenges.

When is the next results date for Mardia Samyoung Capillary Tubes Company Ltd?

The next results date for Mardia Samyoung Capillary Tubes Company Ltd is January 24, 2026.

The next results date for Mardia Samyoung Capillary Tubes Company Ltd is scheduled for January 24, 2026.

Why is Mardia Samyoung Capillary Tubes Company Ltd falling/rising?

As of 03-Apr, Mardia Samyoung Capillary Tubes Company Ltd's stock price is declining at 95.48, down 1.99% today and 5.84% over the last three days. The stock has underperformed its sector and benchmark indices over various time frames, with a year-to-date decline of 16.28%.

As of 03-Apr, Mardia Samyoung Capillary Tubes Company Ltd is experiencing a decline in its stock price, currently at 95.48, which reflects a change of -1.94 (-1.99%). The stock has underperformed its sector by -0.62% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of -5.84% over that period. <BR><BR>In addition to the recent price drop, the stock has shown negative performance over various time frames, with a year-to-date decline of -16.28%, which is worse than the benchmark Sensex's decline of -13.96%. Over the past month, the stock has decreased by -8.54%, again underperforming the Sensex, which fell by -8.62%. <BR><BR>Despite some positive indicators, such as a significant increase in delivery volume by 535.96% on April 1 compared to the 5-day average, the overall trading activity has been erratic, with the stock not trading on 3 out of the last 20 days. Furthermore, while the stock's price is higher than its 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day and 20-day moving averages, indicating a short-term weakness. <BR><BR>These factors collectively contribute to the stock's current downward trajectory.

Why is Mardia Samyoung Capillary Tubes Company Ltd falling/rising?

As of 04-Apr, Mardia Samyoung Capillary Tubes Company Ltd's stock price is at 95.48, down 1.99%, reflecting a broader trend of underperformance with a year-to-date decline of 16.28%. Despite increased investor participation, the stock shows short-term weakness and has experienced consecutive losses over the past three days.

As of 04-Apr, Mardia Samyoung Capillary Tubes Company Ltd's stock price is falling, currently at 95.48, reflecting a decrease of 1.94 or 1.99%. This decline is part of a broader trend, as the stock has underperformed the sector by 0.62% today and has experienced consecutive losses over the past three days, totaling a drop of 5.84% in that period. <BR><BR>In addition to the recent price movements, the stock has shown a year-to-date decline of 16.28%, which is more severe than the Sensex's drop of 13.96%. The stock's performance over the past month also indicates a decrease of 8.54%, closely mirroring the Sensex's decline of 8.62%. Despite being higher than the 50-day, 100-day, and 200-day moving averages, it is currently lower than the 5-day and 20-day moving averages, suggesting a short-term weakness.<BR><BR>Moreover, the stock has not traded on three days out of the last twenty, indicating erratic trading behavior. However, there has been a notable increase in investor participation, with delivery volume rising by 535.96% against the 5-day average on April 1. Despite this increase in participation, the overall trend remains negative, contributing to the stock's current falling price.

Why is Mardia Samyoung Capillary Tubes Company Ltd falling/rising?

As of 05-Apr, Mardia Samyoung Capillary Tubes Company Ltd's stock price is declining at 95.48, down 1.99% over the last three days and 16.28% year-to-date, underperforming the benchmark Sensex. Despite a significant increase in investor participation, the stock continues to face downward pressure and shows signs of short-term weakness.

As of 05-Apr, Mardia Samyoung Capillary Tubes Company Ltd is experiencing a decline in its stock price, currently at 95.48, which reflects a change of -1.94 (-1.99%). The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of -5.84% over the past week. This trend is further supported by a year-to-date drop of -16.28%, which is more significant than the benchmark Sensex's decline of -13.96% during the same period.<BR><BR>Additionally, the stock's performance today has underperformed its sector by -0.62%. Despite trading at a consistent price of 95.48 without any range fluctuations, the stock has shown erratic trading patterns, not trading on three out of the last twenty days. The moving averages indicate that while the stock is higher than the 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day and 20-day moving averages, suggesting a short-term weakness.<BR><BR>On a more positive note, there has been a significant increase in investor participation, with delivery volume rising by 535.96% against the 5-day average on April 1. However, this increase in participation has not translated into a price increase, as the stock continues to face downward pressure. Overall, the combination of consecutive price declines, underperformance relative to the sector, and erratic trading behavior contributes to the current falling trend of Mardia Samyoung Capillary Tubes Company Ltd's stock price.

Which are the latest news on Mardia Samyoung?